Streetbeat News

Earnings

MTB

M&T Bank's shares have seen an increase following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:32 pm

AMGN

DXY

SHEL

On CNBC's 'Halftime Report Final Trades,' analysts highlighted Shell plc (SHEL) for its 12% free cash flow yield and updated FY24 operational outlook, Amgen Inc. (AMGN) for its 3.2% dividend yield and maintained $320 price target by Truist Securities, and the U.S. Dollar Index (DXY) as a pick by Jim Lebenthal. Shell's operational outlook includes adjustments in production and LNG liquefaction volumes, while Amgen's stock was noted for achieving a 52-week high of $329.72 on Feb. 5. Price actions saw Shell and Amgen shares falling slightly, with the U.S. Dollar Index also experiencing a minor drop.

Portfolio Pulse from Avi Kapoor

April 15, 2024 | 12:29 pm

PETS

PetMed Express reported Q3 2024 earnings with a loss of $(0.10) per share, missing the $(0.01) estimate by 900%. However, their sales of $65.317M exceeded the $65.000M estimate, marking a 10.95% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:26 pm

Morgan Stanley (NYSE:MS) is anticipated to release its Q1 earnings on April 16, 2024, with expected earnings of $1.66 per share and revenue of $14.41 billion. JMP Securities analyst Devin Ryan has reiterated a Market Perform rating. The article also explores how to generate a monthly income of $500 from Morgan Stanley's dividends, requiring ownership of approximately 1,765 shares, based on the current dividend yield of 3.94%.

Portfolio Pulse from Avi Kapoor

April 15, 2024 | 12:22 pm

PETS

PetMed Express reported a Q3 2024 GAAP EPS loss of $(0.10) with sales of $65.317M, surpassing the $65.000M estimate. This represents a 10.95% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:21 pm

COGT

MOH

MRNS

NMRA

PSNY

RARE

RDZN

TRMD

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shares plummeted 74.2% in pre-market trading after updating on the Phase 3 RAISE Trial and reporting preliminary Q1 2024 financial results with ZTALMY net revenue of $7.4 to $7.6 million. Other stocks also moved lower in pre-market trading: Neumora Therapeutics, Inc. (NASDAQ:NMRA) dropped 17.1% due to an FDA clinical hold, Roadzen, Inc. (NASDAQ:RDZN) fell 14%, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) declined 11.4% after interim Phase 1/2 data, Cogent Biosciences, Inc. (NASDAQ:COGT) decreased 7.7%, Polestar Automotive Holding UK PLC (NASDAQ:PSNY) dropped 7.2%, Molina Healthcare, Inc. (NYSE:MOH) fell 7.1%, and TORM plc (NASDAQ:TRMD) slipped 3.1%.

Portfolio Pulse from Avi Kapoor

April 15, 2024 | 12:19 pm

CELU

Celularity Inc. (NASDAQ:CELU) announced its Q1 2024 net sales for advanced biomaterial products and biobanking businesses are trending ahead of previous expectations. The company is experiencing its 4th consecutive quarter of sales growth and is implementing SG&A reductions, including executive pay cuts, to invest in production expansion. Celularity's product pipeline includes four commercial-stage products (Biovance®, Biovance® 3L, Interfyl®, CentaFlex®) and three investigational products, with a focus on leveraging its placental-derived technology across various medical indications.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 12:15 pm

DBI

GBX

Insiders at Dollar General, Greenbrier Companies, BJ's Wholesale Club, and Designer Brands have recently sold shares. These sales could indicate various strategic reasons or personal opinions about the company's stock value. Notably, Dollar General had a price target adjustment by Evercore ISI Group, Greenbrier Companies reported a revenue decline but beat consensus, BJ's Wholesale Club was upgraded by Goldman Sachs, and Designer Brands reported a decrease in comparable sales.

Portfolio Pulse from Avi Kapoor

April 15, 2024 | 12:09 pm

DBGI

KAVL

PEV

RENT

SNPO

In Monday's pre-market session, there were notable movements in the consumer discretionary sector. Snap One Holdings, Phoenix Motor, and Kaival Brands Innovations were among the top gainers, with Snap One Holdings leading with a 31.1% increase. On the downside, Kaixin Holdings, ZHONGCHAO, and Lixiang Education Holdings were among the biggest losers. Rent the Runway and Digital Brands Group also reported their Q4 earnings, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 12:07 pm

BMRA

MRNS

SNGX

In Monday's pre-market session, several healthcare stocks showed significant movement. Soligenix, Longeveron, Cartesian Therapeutics, Biomerica, Allarity Therapeutics, and Envoy Medical were among the gainers, with Soligenix leading by a 95.1% increase. On the downside, Marinus Pharma, TRACON Pharma, Neumora Therapeutics, PaxMedica, Alterity Therapeutics, and SINTX Techs faced declines, with Marinus Pharma dropping by 74.5%. Biomerica's rise was attributed to its Q3 earnings release.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 12:07 pm